1-5 of 5
mecasermin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Insulin Receptor Phosphorylation by Endogenous Insulin or the Insulin Analog AspB10 Promotes Mammary Tumor Growth Independent of the IGF-I Receptor

Emily Jane Gallagher, Nyosha Alikhani, Aviva Tobin-Hess, Jeffrey Blank, Nicholas J. Buffin, Zara Zelenko, Norbert Tennagels, Ulrich Werner, Derek LeRoith
Journal: Diabetes
Diabetes 2013;62(10):3553–3560
https://doi.org/10.2337/db13-0249
Published: 17 September 2013
View article titled, Insulin Receptor Phosphorylation by Endogenous Insulin or the Insulin Analog AspB10 Promotes Mammary Tumor Growth Independent of the IGF-I Receptor
Open the PDF for Insulin Receptor Phosphorylation by Endogenous Insulin or the Insulin Analog AspB10 Promotes Mammary Tumor Growth Independent of the IGF-I Receptor in another window
Journal Articles

Effects of Recombinant Human IGF-I/IGF-Binding Protein-3 Complex on Glucose and Glycerol Metabolism in Type 1 Diabetes

Tero Saukkonen, Fariba Shojaee-Moradie, Rachel M. Williams, Rakesh Amin, Kevin C. Yuen, Angie Watts, Carlo L. Acerini, A. Margot Umpleby, David B. Dunger
Journal: Diabetes
Diabetes 2006;55(8):2365–2370
https://doi.org/10.2337/db05-1646
Published: 01 August 2006
View article titled, Effects of Recombinant Human IGF-I/IGF-Binding Protein-3 Complex on Glucose and Glycerol Metabolism in Type 1 Diabetes
Open the PDF for Effects of Recombinant Human IGF-I/IGF-Binding Protein-3 Complex on Glucose and Glycerol Metabolism in Type 1 Diabetes in another window
Journal Articles

rhIGF-I Administration Reduces Insulin Requirements, Decreases Growth Hormone Secretion, and Improves the Lipid Profile in Adults With IDDM

Paul V Carroll, Margot Umpleby, Gill S Ward, Stephen Imuere, Elaine Alexander, David Dunger, Peter H Sönksen, David L Russell-Jones
Journal: Diabetes
Diabetes 1997;46(9):1453–1458
https://doi.org/10.2337/diab.46.9.1453
Published: 01 September 1997
View article titled, rhIGF-I Administration Reduces Insulin Requirements, Decreases Growth Hormone Secretion, and Improves the Lipid Profile in Adults With IDDM
Open the PDF for rhIGF-I Administration Reduces Insulin Requirements, Decreases Growth Hormone Secretion, and Improves the Lipid Profile in Adults With IDDM in another window
Journal Articles

Recombinant Human Insulin-Like Growth Factor I Increases Insulin Sensitivity and Improves Glycemic Control in Type II Diabetes

Alan C Moses, Simon CJ Young, Linda A Morrow, Maureen O'Brien, David R Clemmons
Journal: Diabetes
Diabetes 1996;45(1):91–100
https://doi.org/10.2337/diab.45.1.91
Published: 01 January 1996
View article titled, Recombinant Human Insulin-Like Growth Factor I Increases Insulin Sensitivity and Improves Glycemic Control in Type II Diabetes
Open the PDF for Recombinant Human Insulin-Like Growth Factor I Increases Insulin Sensitivity and Improves Glycemic Control in Type II Diabetes in another window
Journal Articles

Adverse Effects of Recombinant Human Insulin-like Growth Factor I in Obese Insulin-Resistant Type II Diabetic Patients

Nabeel Jabri, Don S Schalch, Sherwyn L Schwartz, Jerome S Fischer, Mark S Kipnes, Barbara J Radnik, Nancy J Turman, Victoria S Marcsisin, Hans-Peter Guler
Journal: Diabetes
Diabetes 1994;43(3):369–374
https://doi.org/10.2337/diab.43.3.369
Published: 01 March 1994
View article titled, Adverse Effects of Recombinant Human Insulin-like Growth Factor I in Obese Insulin-Resistant Type II Diabetic Patients
Open the PDF for Adverse Effects of Recombinant Human Insulin-like Growth Factor I in Obese Insulin-Resistant Type II Diabetic Patients in another window